<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>https://ecency.com</link><image><url>https://ecency.com/logo512.png</url><title>RSS Feed</title><link>https://ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Wed, 02 Sep 2026 17:46:30 GMT</lastBuildDate><atom:link href="https://ecency.com/created/smoblogkidneynews/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[April 3, 2021. Low-Protein Diet Appears to Delay the Progression of Chronic Kidney Disease]]></title><description><![CDATA[This article shows that the lower the protein in the diet, the slower the progression of chronic kidney disease (CKD). This means that it could be used to delay or avoid dialysis initiation. Link to the]]></description><link>https://ecency.com/@secondmedicalop/april-3-2021-low-protein-diet-appears-to-delay-the-progression-of-chronic-kidney-disease</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/april-3-2021-low-protein-diet-appears-to-delay-the-progression-of-chronic-kidney-disease</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 03 Apr 2021 17:42:48 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[March 28, 2021. Increased Physical Activity May Decrease Mortality in Patients With Advanced Chronic Kidney Disease]]></title><description><![CDATA[The linked article states that higher levels of physical activity, as measured by the Physical Activity Scale for the Elderly (PASE) questionnaire could be related to a substantial decrease in mortality.]]></description><link>https://ecency.com/@secondmedicalop/march-28-2021-increased-physical-activity-may-decrease-mortality-in-patients-with-advanced-chronic-kidney-disease</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/march-28-2021-increased-physical-activity-may-decrease-mortality-in-patients-with-advanced-chronic-kidney-disease</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 29 Mar 2021 00:13:12 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[March 27, 2021. There May Be Recovery From Dialysis inPatients with Primary Hyperoxaluria Treated With Pyridoxine]]></title><description><![CDATA[The following article describes 3 cases of patients who recovered from dialysis which was the consequence of primary hyperoxaluria type 1 (PH1). Link to the article. doi: Link To quote this article in]]></description><link>https://ecency.com/@secondmedicalop/march-27-2021-there-may-be-recovery-from-dialysis-inpatients-with-primary-hyperoxaluria-treated-with-pyridoxine</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/march-27-2021-there-may-be-recovery-from-dialysis-inpatients-with-primary-hyperoxaluria-treated-with-pyridoxine</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sun, 28 Mar 2021 03:21:12 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Severe Acute Renal Failure is Associated with Increased Mortality in COVID-19]]></title><description><![CDATA[The inked article shows that there is an association between death and severe acute renal failure. Other variables associated with increased mortality were old age, high neutrophil/lympocyte ratio and]]></description><link>https://ecency.com/@secondmedicalop/severe-acute-renal-failure-is-associated-with-increased-mortality-in-covid-19</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/severe-acute-renal-failure-is-associated-with-increased-mortality-in-covid-19</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 26 Dec 2020 04:56:15 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[The Risk of  Having Kidney Stones May be Causally Related to Vitamin K Deficiency]]></title><description><![CDATA[This article is a very interesting study which relates high levels of desphospho-uncarboxylated Matrix Gla Protein (dp-ucMGP) with the formation of kidney stones. High levels of dp-ucMGP are caused by]]></description><link>https://ecency.com/@secondmedicalop/the-risk-of-having-kidney-stones-may-be-causally-related-to-vitamin-k-deficiency</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/the-risk-of-having-kidney-stones-may-be-causally-related-to-vitamin-k-deficiency</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 13 Jun 2020 04:03:54 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Comparative Renoprotective Effect of Febuxostat and Allopurinol in Predialysis Stage 5 Chronic Kidney Disease Patients: A Nationwide Database Analysis]]></title><description><![CDATA[The following article is observational study which compared the outcome of dialysis between patients with gout or hyperuricemia who already had CKD stage 5 according the the use of allopurinol or febuxostat.]]></description><link>https://ecency.com/@secondmedicalop/comparative-renoprotective-effect-of-febuxostat-and-allopurinol-in-predialysis-stage-5-chronic-kidney-disease-patients-a</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/comparative-renoprotective-effect-of-febuxostat-and-allopurinol-in-predialysis-stage-5-chronic-kidney-disease-patients-a</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 25 May 2020 21:34:57 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[The Circulating Inactive Form of Matrix Gla Protein Is a Surrogate Marker for Vascular Calcification in Chronic Kidney Disease: A Preliminary Report]]></title><description><![CDATA[The following article article is a prospective study which shows that the levels of dephosphorylated uncarboxylated matrix Gla protein (dp-ucMGP) are associated with the degree of vascular calcification]]></description><link>https://ecency.com/@secondmedicalop/the-circulating-inactive-form-of-matrix-gla-protein-is-a-surrogate-marker-for-vascular-calcification-in-chronic-kidney-disease-a</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/the-circulating-inactive-form-of-matrix-gla-protein-is-a-surrogate-marker-for-vascular-calcification-in-chronic-kidney-disease-a</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Fri, 15 May 2020 04:32:57 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[SMO Kidney News - 2019 Index.]]></title><description><![CDATA[This is an index of the articles I have highlighted as SMO Kidney News in 2019. Finding older posts is not that simple and I am trying to simplify the process through this method. I will keep indexing]]></description><link>https://ecency.com/@secondmedicalop/smo-kidney-news-2019-index</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/smo-kidney-news-2019-index</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 11 May 2020 01:46:45 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Octreotide/Midodrine Therapy Significantly Improves Renal Function and 30-Day Survival in Patients with Type 1 Hepatorenal Syndrome]]></title><description><![CDATA[This article is a retrospective cohort study which compares the survival of patients with type 1 hepatorenal syndrome (HRS) who receive therapy with octreotide and midodrine versus the ones who do not]]></description><link>https://ecency.com/@secondmedicalop/octreotide-midodrine-therapy-significantly-improves-renal-function-and-30-day-survival-in-patients-with-type-1-hepatorenal</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/octreotide-midodrine-therapy-significantly-improves-renal-function-and-30-day-survival-in-patients-with-type-1-hepatorenal</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 25 Apr 2020 19:43:39 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Clinical and Pathological Analysis of the Kidney in Patients with Hypertensive Nephropathy]]></title><description><![CDATA[This article is an article which evaluates the pathological characteristics in various patients with clinical hypertensive nephropathy. Chronic benign hypertensive patients exhibited benign arteriolar]]></description><link>https://ecency.com/@secondmedicalop/clinical-and-pathological-analysis-of-the-kidney-in-patients-with-hypertensive-nephropathy</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/clinical-and-pathological-analysis-of-the-kidney-in-patients-with-hypertensive-nephropathy</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 24 Feb 2020 04:58:12 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Renal Autoregulation in Health and Disease]]></title><description><![CDATA[This article is a review article which describes the mechanisms of renal pressure autoregulation. Specifically it describes the myogenic response and a macula densa - tubuloglomerular feedback (MD-TGF).]]></description><link>https://ecency.com/@secondmedicalop/renal-autoregulation-in-health-and-disease</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/renal-autoregulation-in-health-and-disease</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Thu, 13 Feb 2020 02:59:51 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Glucose Handling by the Kidney]]></title><description><![CDATA[This article is a review article which describes the kidney role in the homeostasis of glucose, in the normal kidney and the diabetic kidney. the kidney participates in the gluconeogenesis, glucose filtration,]]></description><link>https://ecency.com/@secondmedicalop/glucose-handling-by-the-kidney</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/glucose-handling-by-the-kidney</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sun, 02 Feb 2020 21:19:39 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Serum levels of NGAL and Cystatin C as Markers of Early Kidney Dysfunction in Patients with Obstructive Sleep Apnea Syndrome]]></title><description><![CDATA[This article is a study which establishes an association between higher neutrophil gelatinase-associated lipocalin (NGAL) levels and cystatin C levels and the presence of obstructive sleep apnea (OSA).]]></description><link>https://ecency.com/@secondmedicalop/serum-levels-of-ngal-and-cystatin-c-as-markers-of-early-kidney-dysfunction-in-patients-with-obstructive-sleep-apnea-syndrome</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/serum-levels-of-ngal-and-cystatin-c-as-markers-of-early-kidney-dysfunction-in-patients-with-obstructive-sleep-apnea-syndrome</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 20 Jan 2020 03:02:30 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Mechanisms of caffeine-induced diuresis (French)]]></title><description><![CDATA[This article is a review of the mechanisms known to explain the diuretic effect of caffeine. Caffeine inhibits the vasoconstriction mediated by the type 1 adenosine receptor in afferent arteriole increasing]]></description><link>https://ecency.com/@secondmedicalop/mechanisms-of-caffeine-induced-diuresis-french</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/mechanisms-of-caffeine-induced-diuresis-french</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 18 Jan 2020 04:47:42 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Requirement of Intact Adenosine A1 Receptors for the Diuretic and Natriuretic Action of the Methylxanthines Theophylline and Caffeine]]></title><description><![CDATA[This article is study that shows how A1 adenosine receptors are needed for the diuretic and natriuertic effects of methylxanthines such as theophylline and caffeine. The blockade of these receptors caused]]></description><link>https://ecency.com/@secondmedicalop/requirement-of-intact-adenosine-a1-receptors-for-the-diuretic-and-natriuretic-action-of-the-methylxanthines-theophylline-and</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/requirement-of-intact-adenosine-a1-receptors-for-the-diuretic-and-natriuretic-action-of-the-methylxanthines-theophylline-and</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 11 Jan 2020 00:52:06 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Metabolic Acidosis and Thiamine Deficiency]]></title><description><![CDATA[This article is a case report of metabolic acidosis (lactic acidosis) caused by thiamine deficiency. Thiamine is a a cofactor for the pyruvate dehydrogenase enzymatic complex. Its deficiency causes an]]></description><link>https://ecency.com/@secondmedicalop/metabolic-acidosis-and-thiamine-deficiency</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/metabolic-acidosis-and-thiamine-deficiency</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Tue, 07 Jan 2020 03:58:27 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Decreased renal function in hypertensive emergencies]]></title><description><![CDATA[This article shows a cross sectional study in which shows that markers of acute kidney injury are present in hypertensive emergencies more than in hypertensive urgencies or controls. One of the markers]]></description><link>https://ecency.com/@secondmedicalop/decreased-renal-function-in-hypertensive-emergencies</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/decreased-renal-function-in-hypertensive-emergencies</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Mon, 06 Jan 2020 03:31:09 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Vitamin C-Induced Oxalate Nephropathy]]></title><description><![CDATA[This article is a case report of oxalate nephropathy caused by high doses of vitamin C. In the article, the patient presented with acute kidney failure requiring dialysis. When questioned about diet he]]></description><link>https://ecency.com/@secondmedicalop/vitamin-c-induced-oxalate-nephropathy</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/vitamin-c-induced-oxalate-nephropathy</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 04 Jan 2020 04:15:36 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Pigment Nephropathy: Novel Insights into Inflammasome-Mediated Pathogenesis]]></title><description><![CDATA[This article is a review of the pathogenesis of pigment nephropathy, mediated by the inflammasome pathway. In essence, the filtered hem groups can trigger an inflammatory response when reabsorbed by the]]></description><link>https://ecency.com/@secondmedicalop/pigment-nephropathy-novel-insights-into-inflammasome-mediated-pathogenesis</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/pigment-nephropathy-novel-insights-into-inflammasome-mediated-pathogenesis</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Thu, 02 Jan 2020 02:23:33 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Fibroblast Growth Factor 23 (FGF23) Predicts Progression of Chronic Kidney Disease: The Mild to Moderate Kidney Disease (MMKD) Study]]></title><description><![CDATA[This article is a cohort study of non diabetic patients with chronic kidney disease which shows that fibroblast growth factor 23 (FGF23) is an independent predictor of progression of chronic kidney disease.]]></description><link>https://ecency.com/@secondmedicalop/fibroblast-growth-factor-23-fgf23-predicts-progression-of-chronic-kidney-disease-the-mild-to-moderate-kidney-disease-mmkd-study</link><guid isPermaLink="true">https://ecency.com/@secondmedicalop/fibroblast-growth-factor-23-fgf23-predicts-progression-of-chronic-kidney-disease-the-mild-to-moderate-kidney-disease-mmkd-study</guid><category><![CDATA[hive-163521]]></category><dc:creator><![CDATA[secondmedicalop]]></dc:creator><pubDate>Sat, 28 Dec 2019 01:38:03 GMT</pubDate><enclosure url="https://i.ecency.com/p/W5LtFUPm6g7111bbdcuxu3bfUg5qaCq8seb5paCtrrT7zMaZC32aV8dx4phCidrnWQayfWEA6cHbTj9AViqM53E12gVtamE9ezi1JRKgJ99RB9SCDgvQ6LESiaiH6UoCoi7Nm6FkzBhrnQ2wrDWD9mdjUqMAW?format=match&amp;mode=fit" length="0" type="false"/></item></channel></rss>